ArticleDiabetology & metabolic syndrome2026
Epidemiological features of pediatric nonalcoholic fatty liver disease in China.
Article in Diabetology & metabolic syndrome, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveNon-alcoholic fatty-liver disease (NAFLD) among children and adolescents in China has emerged as a significant public-health concern, that requires greater attention. This study aims to estimate the prevalence of pediatric NAFLD and its epidemiological characteristics.
methodsFour English-language and two Chinese-language databases were systematically searched for relevant articles published before January 1st, 2025. Rigorous inclusion and exclusion criteria were applied to screen articles and extract NAFLD prevalence data. The pooled overall prevalence of NAFLD with 95% confidence intervals (CIs) was calculated using the Freeman-Tukey Double Arcsine Transformation Method. Moreover, subgroup analysis was conducted to compare NAFLD prevalence across different categories, including region, income, age, and gender.
resultsThe study encompassed 126,682 participants from 219 studies. The nationwide prevalence of pediatric NAFLD in China was 22.82%. Higher prevalence rates were observed among boy, older age groups, individuals in southern and northeastern regions, and those classified as obese or overweight. Furthermore, epidemiological pattern analysis of children with NAFLD identified metabolic, endocrine, and lifestyle factors as crucial determinants in pediatric NAFLD progression.
conclusionsConsidering the substantial burden of pediatric NAFLD in China, researchers must conduct effective intervention studies to address its epidemiological status. Additionally, governmental action is required to enhance public awareness and establish health policies aimed at controlling the NAFLD epidemic among Chinese children.
trial registrationThe registration number was CRD42020206731.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.